经膀胱入路国产单孔手术机器人辅助腹腔镜下根治性前列腺切除术初步经验  

Preliminary experience of domestic single-port transvesical robotassisted radical prostatectomy

作　　者：张成[1] 黄伟[1] 关龙辉 周延煜 庄锦标 边启涛 郭炬[1] 周强 傅斌[1] 王共先[1] ZHANG Cheng;HUANG Wei;GUAN Longhui;ZHOU Yanyu;ZHUANG Jinbiao;BIAN Qitao;GUO Ju;ZHOU Qiang;FU Bin;WANG Gongxian(Department of Urology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China)

机构地区：[1]南昌大学第一附属医院泌尿外科,江西南昌330006

出　　处：《机器人外科学杂志（中英文）》2024年第6期1018-1023,共6页Chinese Journal of Robotic Surgery

基　　金：国家自然科学基金(82260527)。

摘　　要：目的:探讨经膀胱入路国产单孔手术机器人辅助腹腔镜下根治性前列腺切除术治疗前列腺癌患者的有效性和安全性。方法:选取2022年12月—2023年3月于南昌大学第一附属医院行经膀胱入路单孔手术机器人辅助腹腔镜下根治性前列腺切除术的3例患者临床资料,并记录、分析患者术后尿控恢复时间和手术切缘等情况。结果:3例手术均顺利完成,未发生中转开放手术或增加辅助手术通道。平均手术时间为262(209~334)min,平均出血量500(300~800)mL,术后3个月尿控良好,均无Clavien分级Ⅱ级以上并发症发生。结论:经膀胱入路国产单孔手术机器人辅助腹腔镜下根治性前列腺切除术在前列腺癌患者中的应用是有效且安全的,但本研究病例数有限,大样本及长期的肿瘤控制需进一步研究。Objective:To evaluate the efficacy and safety of single-port transvesical robot-assisted radical prostatectomy(RARP)in patients with prostate cancer.Methods:Clinical data of 3 patients who underwent single-port transvesical RARP for localized prostate cancer in the First Affiliated Hospital of Nanchang University from December 2022 to March 2023 were prospectively collected and analyzed.Results:All surgeries were successfully completed without conversion to open surgery,and no extra auxiliary channels added.Urinary continence of the three patients were all recovered well,with the average operative time of 262(209-334)min and the average blood loss of 500(300-800)mL.1 case of positive surgical margins was found.No complications of Clavien grade II or above occurred.Conclusion:Single-port transvesical RARP is an effective and safe alternative for the treatment of prostate cancer.However,the number of cases in this study is limited,studies with large sample and long-term tumor control are needed to further confirm these results.

关 键 词：单孔手术机器人 机器人辅助手术 根治性前列腺切除术 经膀胱入路 

分 类 号：R737.25[医药卫生—肿瘤]